https://scholars.lib.ntu.edu.tw/handle/123456789/521274
標題: | Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan | 作者: | Yeh C.-N. Hwang T.-L. Huang C.-S. PO-HUANG LEE Wu C.-W. Chen-Guo K. Jan Y.-Y. Chen M.-F. |
關鍵字: | Gastrointestinal stromal tumors; Guidelines; Imatinib; Targeted; Treatment | 公開日期: | 2012 | 卷: | 10 | 起(迄)頁: | 246 | 來源出版物: | World Journal of Surgical Oncology | 摘要: | For many years, the understanding of gastrointestinal stromal tumors (GISTs), which are the most common mesenchymal tumors of the gastrointestinal tract, has been very limited. However, it is now possible to provide a more precise definition through the use of pathology classification and molecular techniques. Coupled with the advancement of clinical practice, especially the development of targeted therapy, there is now a much better insight into its treatment. At present, organizations such as the National Comprehensive Cancer Network in the USA and the European Society for Medical Oncology in Europe have established a consensus and drawn up guidelines for the diagnosis, treatment, and follow-up of GISTs.With experts coming from various districts in Taiwan and combining the most recent clinical data and experiences, the Taiwan Surgical Society of Gastroenterology drafted the first national GIST treatment guidelines after a consensus meeting in 2007. Following subsequent advances in GIST diagnosis and treatment, further revisions and modifications have been made to the original guidelines. We present here the updated consensus and recommendations of the Taiwan Surgical Society of Gastroenterology for the diagnosis and treatment of GIST. We hope these guidelines can help enhance the quality of diagnosis, treatment, and care of patients with GIST in Taiwan. ? 2012 Yeh et al.; licensee BioMed Central Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868674477&doi=10.1186%2f1477-7819-10-246&partnerID=40&md5=8dd055940645db4388b18281e3c0c67f https://scholars.lib.ntu.edu.tw/handle/123456789/521274 |
ISSN: | 1477-7819 | DOI: | 10.1186/1477-7819-10-246 | SDG/關鍵字: | imatinib; placebo; stem cell factor; sunitinib; cancer chemotherapy; cancer diagnosis; cancer radiotherapy; cancer surgery; computer assisted tomography; exon; follow up; gastrointestinal stromal tumor; gene mutation; human; metastasis; nuclear magnetic resonance imaging; positron emission tomography; practice guideline; review; Taiwan; digestive system examination; gastrointestinal stromal tumor; incidence; multimodality cancer therapy; practice guideline; standard; Taiwan; Combined Modality Therapy; Diagnostic Techniques, Digestive System; Gastrointestinal Stromal Tumors; Humans; Incidence; Practice Guidelines as Topic; Taiwan |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。